Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 23 | 2024 | 956 | 4.010 |
Why?
|
Receptors, Antigen, T-Cell | 26 | 2024 | 276 | 3.440 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 12 | 2020 | 112 | 3.310 |
Why?
|
Peptides | 14 | 2024 | 546 | 2.020 |
Why?
|
Histocompatibility Antigens | 8 | 2015 | 107 | 1.970 |
Why?
|
Thymus Gland | 9 | 2024 | 222 | 1.800 |
Why?
|
Major Histocompatibility Complex | 7 | 2024 | 87 | 1.460 |
Why?
|
T-Lymphocytes, Regulatory | 6 | 2019 | 194 | 1.410 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 605 | 1.320 |
Why?
|
Complementarity Determining Regions | 4 | 2016 | 37 | 1.310 |
Why?
|
Autoimmunity | 9 | 2019 | 223 | 1.290 |
Why?
|
CD4-Positive T-Lymphocytes | 10 | 2023 | 606 | 1.160 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2023 | 646 | 1.100 |
Why?
|
Autoantigens | 7 | 2024 | 125 | 1.050 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 3 | 2020 | 54 | 0.970 |
Why?
|
T-Lymphocyte Subsets | 6 | 2020 | 237 | 0.960 |
Why?
|
Cell Differentiation | 11 | 2024 | 1289 | 0.850 |
Why?
|
Animals | 47 | 2024 | 19516 | 0.830 |
Why?
|
Histocompatibility Antigens Class II | 10 | 2023 | 178 | 0.830 |
Why?
|
Self Tolerance | 3 | 2019 | 18 | 0.820 |
Why?
|
Mice | 34 | 2024 | 10207 | 0.780 |
Why?
|
Immune Tolerance | 6 | 2014 | 169 | 0.720 |
Why?
|
Mice, Inbred C57BL | 17 | 2023 | 3168 | 0.680 |
Why?
|
Lymphocyte Activation | 10 | 2020 | 736 | 0.680 |
Why?
|
Myelin Basic Protein | 6 | 2007 | 23 | 0.670 |
Why?
|
Monocytes | 1 | 2020 | 350 | 0.610 |
Why?
|
Antigen-Presenting Cells | 5 | 2015 | 177 | 0.570 |
Why?
|
H-2 Antigens | 4 | 2011 | 60 | 0.570 |
Why?
|
Dengue | 1 | 2017 | 93 | 0.570 |
Why?
|
Dengue Virus | 1 | 2017 | 95 | 0.560 |
Why?
|
Mice, Knockout | 9 | 2020 | 1983 | 0.490 |
Why?
|
Adaptive Immunity | 1 | 2015 | 89 | 0.470 |
Why?
|
Central Nervous System | 3 | 2014 | 190 | 0.460 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 35 | 0.460 |
Why?
|
Multiple Sclerosis | 3 | 2014 | 204 | 0.450 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 56 | 0.440 |
Why?
|
Vaccinia | 1 | 2012 | 31 | 0.420 |
Why?
|
Vaccinia virus | 1 | 2012 | 71 | 0.410 |
Why?
|
Antigens, Viral | 1 | 2012 | 131 | 0.400 |
Why?
|
Mice, Transgenic | 11 | 2023 | 1219 | 0.390 |
Why?
|
Antigens | 3 | 2015 | 146 | 0.320 |
Why?
|
Models, Immunological | 4 | 2015 | 79 | 0.310 |
Why?
|
Ligands | 6 | 2014 | 420 | 0.310 |
Why?
|
Mice, Inbred NOD | 2 | 2023 | 509 | 0.310 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2017 | 163 | 0.300 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2014 | 130 | 0.290 |
Why?
|
Spinal Cord | 2 | 2014 | 195 | 0.280 |
Why?
|
Thymocytes | 2 | 2024 | 17 | 0.270 |
Why?
|
Interleukin-2 | 4 | 2023 | 162 | 0.260 |
Why?
|
Cross Reactions | 5 | 2012 | 123 | 0.260 |
Why?
|
Amino Acids | 1 | 2006 | 140 | 0.250 |
Why?
|
Humans | 24 | 2024 | 58948 | 0.250 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2005 | 57 | 0.240 |
Why?
|
Protein Binding | 6 | 2018 | 1542 | 0.240 |
Why?
|
Interleukin-17 | 2 | 2020 | 80 | 0.240 |
Why?
|
Clonal Deletion | 1 | 2004 | 11 | 0.230 |
Why?
|
Forkhead Transcription Factors | 4 | 2019 | 117 | 0.220 |
Why?
|
Homeodomain Proteins | 2 | 2017 | 254 | 0.220 |
Why?
|
Antibodies | 1 | 2004 | 176 | 0.220 |
Why?
|
Immune System | 1 | 2004 | 129 | 0.210 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2004 | 177 | 0.210 |
Why?
|
Peptide Fragments | 6 | 2011 | 350 | 0.210 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 222 | 0.200 |
Why?
|
Cryptosporidium | 1 | 2021 | 5 | 0.200 |
Why?
|
Cryptosporidiosis | 1 | 2021 | 9 | 0.200 |
Why?
|
Perception | 1 | 2022 | 177 | 0.190 |
Why?
|
Signal Transduction | 8 | 2024 | 2881 | 0.180 |
Why?
|
Cell Line | 3 | 2019 | 2011 | 0.180 |
Why?
|
T-Cell Antigen Receptor Specificity | 3 | 2016 | 10 | 0.180 |
Why?
|
Epigenomics | 1 | 2020 | 54 | 0.180 |
Why?
|
Myelin Proteolipid Protein | 1 | 2000 | 7 | 0.180 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 20 | 0.170 |
Why?
|
CD3 Complex | 2 | 2018 | 63 | 0.170 |
Why?
|
Biomarkers | 3 | 2020 | 1200 | 0.170 |
Why?
|
Brain | 2 | 2014 | 1476 | 0.170 |
Why?
|
Nervous System | 1 | 2000 | 69 | 0.170 |
Why?
|
Immunodominant Epitopes | 1 | 1999 | 57 | 0.160 |
Why?
|
Protein-Arginine Deiminases | 1 | 2019 | 85 | 0.160 |
Why?
|
Insulin | 1 | 2023 | 682 | 0.160 |
Why?
|
Models, Molecular | 4 | 2011 | 1113 | 0.150 |
Why?
|
Immunomodulation | 1 | 2018 | 27 | 0.150 |
Why?
|
Lymph Nodes | 3 | 2016 | 210 | 0.150 |
Why?
|
Adoptive Transfer | 2 | 2012 | 145 | 0.150 |
Why?
|
Transcriptome | 1 | 2020 | 319 | 0.150 |
Why?
|
Serogroup | 1 | 2017 | 30 | 0.150 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2017 | 68 | 0.140 |
Why?
|
Flow Cytometry | 5 | 2014 | 667 | 0.140 |
Why?
|
Cell Proliferation | 5 | 2016 | 936 | 0.140 |
Why?
|
Germ Cells | 1 | 2017 | 96 | 0.140 |
Why?
|
Wasting Syndrome | 1 | 2016 | 7 | 0.140 |
Why?
|
Central Tolerance | 1 | 2016 | 2 | 0.140 |
Why?
|
Cells, Cultured | 4 | 2016 | 2090 | 0.130 |
Why?
|
Colitis | 1 | 2016 | 75 | 0.130 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 99 | 0.120 |
Why?
|
Aging | 1 | 2001 | 720 | 0.120 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 247 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 248 | 0.120 |
Why?
|
Interferon-gamma | 3 | 2014 | 536 | 0.120 |
Why?
|
Protein Conformation | 3 | 2011 | 762 | 0.120 |
Why?
|
Mice, Inbred Strains | 1 | 2014 | 183 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2020 | 2043 | 0.110 |
Why?
|
Antigens, Neoplasm | 3 | 2002 | 133 | 0.110 |
Why?
|
Astrocytes | 1 | 2014 | 113 | 0.110 |
Why?
|
Antigen Presentation | 4 | 2008 | 227 | 0.110 |
Why?
|
Amino Acid Sequence | 6 | 2008 | 1576 | 0.110 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 90 | 0.100 |
Why?
|
Mutation | 2 | 2018 | 2420 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2017 | 758 | 0.100 |
Why?
|
Kinetics | 2 | 2014 | 728 | 0.100 |
Why?
|
Immunological Synapses | 1 | 2012 | 8 | 0.100 |
Why?
|
Immunohistochemistry | 1 | 2014 | 846 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2013 | 139 | 0.100 |
Why?
|
Time Factors | 4 | 2010 | 3551 | 0.100 |
Why?
|
Alleles | 2 | 2005 | 424 | 0.090 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 1126 | 0.090 |
Why?
|
Cytokines | 2 | 2012 | 903 | 0.090 |
Why?
|
Mice, Inbred C3H | 2 | 2001 | 174 | 0.090 |
Why?
|
Hybridomas | 3 | 2005 | 66 | 0.090 |
Why?
|
Half-Life | 1 | 2010 | 70 | 0.090 |
Why?
|
Glycoproteins | 1 | 2011 | 192 | 0.090 |
Why?
|
Solubility | 1 | 2010 | 173 | 0.090 |
Why?
|
Male | 4 | 2019 | 27335 | 0.080 |
Why?
|
Baculoviridae | 2 | 2006 | 26 | 0.080 |
Why?
|
Peptide Library | 2 | 2006 | 35 | 0.080 |
Why?
|
Female | 5 | 2019 | 30624 | 0.080 |
Why?
|
Molecular Sequence Data | 4 | 2006 | 1972 | 0.070 |
Why?
|
Gene Expression | 3 | 2020 | 805 | 0.070 |
Why?
|
Dendritic Cells | 2 | 2021 | 506 | 0.070 |
Why?
|
Interleukin-6 | 2 | 2007 | 307 | 0.070 |
Why?
|
Cytokine Receptor gp130 | 1 | 2007 | 2 | 0.070 |
Why?
|
Immunologic Memory | 2 | 2023 | 276 | 0.070 |
Why?
|
Homeostasis | 2 | 2021 | 335 | 0.070 |
Why?
|
Spodoptera | 1 | 2006 | 27 | 0.070 |
Why?
|
STAT3 Transcription Factor | 1 | 2007 | 68 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2007 | 108 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2004 | 357 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2008 | 304 | 0.060 |
Why?
|
Germ-Line Mutation | 1 | 2005 | 47 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2002 | 579 | 0.060 |
Why?
|
Peripheral Tolerance | 1 | 2024 | 3 | 0.060 |
Why?
|
Binding Sites | 1 | 2006 | 872 | 0.060 |
Why?
|
Models, Biological | 1 | 2008 | 1137 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2001 | 229 | 0.050 |
Why?
|
History, 20th Century | 1 | 2004 | 227 | 0.050 |
Why?
|
Tuberculosis, Gastrointestinal | 1 | 2002 | 4 | 0.050 |
Why?
|
Gastrointestinal Agents | 1 | 2002 | 27 | 0.050 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2001 | 10 | 0.050 |
Why?
|
Clone Cells | 1 | 2001 | 104 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2001 | 55 | 0.050 |
Why?
|
Gene Dosage | 1 | 2001 | 60 | 0.050 |
Why?
|
Sexual Maturation | 1 | 2001 | 50 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2004 | 864 | 0.050 |
Why?
|
Intestines | 1 | 2021 | 156 | 0.050 |
Why?
|
Crohn Disease | 1 | 2002 | 105 | 0.040 |
Why?
|
Th1 Cells | 2 | 2014 | 170 | 0.040 |
Why?
|
Mice, SCID | 1 | 2001 | 501 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2000 | 72 | 0.040 |
Why?
|
Spleen | 3 | 2007 | 485 | 0.040 |
Why?
|
Interleukins | 1 | 2020 | 77 | 0.040 |
Why?
|
Keratinocytes | 1 | 2020 | 63 | 0.040 |
Why?
|
Mice, Inbred A | 1 | 1999 | 20 | 0.040 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1999 | 29 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2020 | 229 | 0.040 |
Why?
|
Receptor, ErbB-2 | 2 | 1996 | 50 | 0.040 |
Why?
|
Antibodies, Neoplasm | 2 | 1996 | 27 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2000 | 121 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2018 | 191 | 0.040 |
Why?
|
Skin | 1 | 2020 | 350 | 0.040 |
Why?
|
Multiprotein Complexes | 1 | 2018 | 148 | 0.030 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2016 | 6 | 0.030 |
Why?
|
Clonal Selection, Antigen-Mediated | 1 | 2016 | 4 | 0.030 |
Why?
|
Tetanus Toxoid | 1 | 1996 | 14 | 0.030 |
Why?
|
Antibody Formation | 1 | 1996 | 111 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 1996 | 176 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1995 | 56 | 0.030 |
Why?
|
Insecta | 2 | 2006 | 38 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2014 | 549 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 1996 | 228 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 1995 | 93 | 0.030 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2014 | 8 | 0.030 |
Why?
|
Vaccines | 1 | 1996 | 96 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2014 | 49 | 0.030 |
Why?
|
Markov Chains | 1 | 2014 | 36 | 0.030 |
Why?
|
Calcium | 2 | 2012 | 550 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 1995 | 275 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 212 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 1995 | 315 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2017 | 1303 | 0.030 |
Why?
|
Infant | 1 | 2017 | 1512 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2004 | 52 | 0.030 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2012 | 5 | 0.030 |
Why?
|
B7-1 Antigen | 2 | 2004 | 73 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 1817 | 0.030 |
Why?
|
Microscopy, Atomic Force | 1 | 2012 | 28 | 0.030 |
Why?
|
Lipid Bilayers | 1 | 2012 | 49 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2012 | 102 | 0.020 |
Why?
|
Tyrosine | 1 | 2012 | 95 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2011 | 46 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 249 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 253 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2012 | 216 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 418 | 0.020 |
Why?
|
Lipids | 1 | 2012 | 302 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 414 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2010 | 373 | 0.020 |
Why?
|
Ovalbumin | 2 | 2000 | 112 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2008 | 33 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2008 | 99 | 0.020 |
Why?
|
Child | 1 | 2017 | 4250 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2008 | 170 | 0.020 |
Why?
|
Cell Membrane | 1 | 2010 | 489 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2007 | 12 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2007 | 84 | 0.020 |
Why?
|
Arthritis, Experimental | 1 | 2007 | 29 | 0.020 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2007 | 25 | 0.020 |
Why?
|
Lymphocyte Transfusion | 1 | 2007 | 37 | 0.020 |
Why?
|
Cell Count | 1 | 2007 | 128 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 1 | 2007 | 55 | 0.020 |
Why?
|
Computational Biology | 1 | 2008 | 323 | 0.020 |
Why?
|
Enterotoxins | 1 | 2006 | 21 | 0.020 |
Why?
|
Proteins | 1 | 2012 | 741 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 1360 | 0.010 |
Why?
|
Gene Library | 1 | 2004 | 99 | 0.010 |
Why?
|
DNA, Viral | 1 | 2004 | 228 | 0.010 |
Why?
|
Epitopes | 1 | 2004 | 298 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 394 | 0.010 |
Why?
|
Cell Extracts | 1 | 2002 | 24 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2004 | 205 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 52 | 0.010 |
Why?
|
Enteritis | 1 | 2002 | 10 | 0.010 |
Why?
|
fas Receptor | 1 | 2002 | 54 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 98 | 0.010 |
Why?
|
ras Proteins | 1 | 2002 | 78 | 0.010 |
Why?
|
Infliximab | 1 | 2002 | 52 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 123 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 201 | 0.010 |
Why?
|
Cell Division | 1 | 2002 | 441 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 2000 | 8 | 0.010 |
Why?
|
Hemocyanins | 1 | 2000 | 23 | 0.010 |
Why?
|
CD40 Antigens | 1 | 2000 | 60 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2000 | 92 | 0.010 |
Why?
|
Mice, Neurologic Mutants | 1 | 1999 | 14 | 0.010 |
Why?
|
Cell Communication | 1 | 2000 | 129 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2002 | 894 | 0.010 |
Why?
|
Oligopeptides | 1 | 1999 | 131 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 251 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 2002 | 375 | 0.010 |
Why?
|
Radiation Chimera | 1 | 1997 | 57 | 0.010 |
Why?
|
Alum Compounds | 1 | 1996 | 3 | 0.010 |
Why?
|
Injections, Intradermal | 1 | 1996 | 5 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 1996 | 22 | 0.010 |
Why?
|
Freund's Adjuvant | 1 | 1996 | 13 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1996 | 51 | 0.010 |
Why?
|
Hematopoiesis | 1 | 1997 | 121 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1997 | 211 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1996 | 69 | 0.010 |
Why?
|
Antigen-Antibody Reactions | 1 | 1995 | 12 | 0.010 |
Why?
|
Oncogene Protein p21(ras) | 1 | 1995 | 5 | 0.010 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 1995 | 32 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 453 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 1996 | 192 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1996 | 450 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1997 | 374 | 0.010 |
Why?
|
Rats | 1 | 1996 | 1904 | 0.010 |
Why?
|
Middle Aged | 1 | 2002 | 16160 | 0.000 |
Why?
|